Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/04/22 06:27
2015/04/22 06:27
4d
Revenue from Kadcyla, also for breast cancer, climbed 80 percent to 179 million francs. Sales of Rituxan, Roche’s top-selling drug for leukemia and rheumatoid arthritis, rose 5 percent to 1.7...
2015/04/22 06:27
2015/04/22 06:27
Latest videos
2015/04/20 13:27
2015/04/20 13:27
6d
... faces imminent competition from makers of biosimilar copies of cancer drugs Herceptin and Rituxan as they lose patent protection. “It’s still early days” for cancer immunotherapy, Chen...
2015/04/09 23:27
2015/04/09 23:27
16d
... drug development strategy that already has already met with some success. Roche’s top-seller Rituxan, which targets errant immune cells, was originally a treatment for lymphoma. It’s now also...
2015/04/02 21:42
2015/04/02 21:42
23d
... Biopharma-Reporter, pharmaceutical consultant Saurabh Aggarwal deemed Gazyva the “Son of Rituxan”, which is a treatment in Biogen Idec’s portfolio that targets the antigen CD-20 in...
2015/04/22 06:27
2015/04/22 06:27
Latest from Twitter